Should NIPT be offered to all pregnant women? Why the ongoing debate?
1. What is NIPT?
NIPT stands for Non-Invasive Prenatal Testing. It involves drawing a simple blood sample from the mother to analyze fetal DNA, screening for chromosomal conditions like Down syndrome, Edwards syndrome, or Patau syndrome. While reliable, results aren't 100% definitive. Unlike invasive tests such as amniocentesis or chorionic villus sampling, NIPT poses no added miscarriage risk.
2. Sounds beneficial—why the controversy?
Wider access empowers more parents to make informed choices about pregnancies involving Down syndrome. In Iceland and Denmark, for example, nearly no children with Down syndrome are born after introducing broad screening. Not everyone supports this trend, sparking ethical discussions.
3. Who qualifies for the test now?
Currently, only women with elevated risk factors are eligible. Some travel to Belgium for access. On Tuesday, Health Minister Edith Schippers emphasized that expanding availability requires careful consideration.
The national government offers a brochure on Down syndrome screening.
